![Gordon Treadway](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon Treadway
Präsident bei Culture Partners
Aktive Positionen von Gordon Treadway
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Culture Partners
![]() Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | Präsident | 01.01.2013 | - |
Vorstandsvorsitzender | 01.01.2016 | - |
Karriereverlauf von Gordon Treadway
Ehemalige bekannte Positionen von Gordon Treadway
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Vertrieb & Marketing | 01.01.2007 | 03.02.2014 |
Ausbildung von Gordon Treadway
Brigham Young University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Culture Partners
![]() Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | Commercial Services |
- Börse
- Insiders
- Gordon Treadway
- Erfahrung